.SecAzar Statement on New Partnership to Develop National Strategy for COVID-19 Therapies and Vaccines | Read the full statement at:
“The ACTIV partnership will bring new levels of coordination and speed to public and private work on therapies and vaccines for COVID-19—work that NIH, HHS, and the Trump Administration began literally days after the coronavirus threat was identified in China in January. To save lives and bring life back to normal in the United States and around the world, we need COVID-19 vaccines and therapies on the market as soon as possible.
By bringing together 16 pharmaceutical companies and five government agencies here and abroad, the ACTIV partnership will accelerate the amazing work being done every day by scientists and innovators inside and outside of government. NIH has an extensive track record of coordinating these development efforts for new biological threats, and they are well-suited to lead this part of the whole-of-government, whole-of-America response President Trump has marshaled to defeat COVID-19.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
How COVID-19 Is Wreaking Havoc On Our Ability To Make Things — Including VaccinesSo far, Australia has been doing pretty well in the fight against COVID-19. Using a combination of social distancing, tight travel restrictions and contact trac…
続きを読む »
Experts call for new national public health workforce to trace spread of COVID-19 casesIt starts with a phone call from a public health worker: You’ve been in contact with someone who has COVID-19. If you’re feeling sick, you may be asked to self-isolate, get a coronavirus test, and share the contact information for everyone you’ve recently interacted with. The practice, known as contact
続きを読む »
Sean Penn Working On Establishing COVID-19 Testing Sites In SoCal, Envisions National RolloutSean Penn, founder of the Community Organized Relief Effort (CORE) disaster relief charity, is focusing his efforts on coronavirus testing in Southern California. CORE has teamed up with Los Angele…
続きを読む »
Gupta: Federal guidance, Singapore-developed tech needed to fight COVID-19“What we need is creative thinking,' VinGuptaMD says of U.S. issues with testing for COVID-19. 'There are ways to get around these bottlenecks, we just have to have federal guidance.”
続きを読む »
Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19“Did remdesivir just ‘solve’ COVID? No,” says Umer Raffat, an analyst at Evercore ISI.
続きを読む »